Drugs Made In America Acquisition Corp. Files 8-K
Ticker: DMAAR · Form: 8-K · Filed: Feb 24, 2025 · CIK: 2028614
| Field | Detail |
|---|---|
| Company | Drugs Made In America Acquisition Corp. (DMAAR) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
TL;DR
DMAA filed an 8-K on 2/24 for events on 2/20 - check it out.
AI Summary
Drugs Made In America Acquisition Corp. filed an 8-K on February 24, 2025, reporting an event on February 20, 2025. The filing pertains to 'Other Events' and 'Financial Statements and Exhibits'. The company is incorporated in the Cayman Islands and its principal executive offices are located in Fort Lauderdale, FL.
Why It Matters
This 8-K filing indicates that Drugs Made In America Acquisition Corp. has reported significant events or filed financial statements, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting events and financial statements, without immediate indication of significant financial distress or major corporate changes.
Key Numbers
- 001-42467 — SEC File Number (Identifies the company's filing history with the SEC.)
- 99-2394788 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Drugs Made In America Acquisition Corp. (company) — Registrant
- February 20, 2025 (date) — Date of earliest event reported
- February 24, 2025 (date) — Date of Report
- Cayman Islands (jurisdiction) — State or other jurisdiction of incorporation
- Fort Lauderdale, FL (location) — Address of Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Drugs Made In America Acquisition Corp. in this 8-K?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the provided text excerpt.
What is the significance of filing 'Financial Statements and Exhibits' on this 8-K?
This indicates that the company is providing updated financial information or exhibits as part of its regulatory reporting requirements.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 20, 2025.
Where are the principal executive offices of Drugs Made In America Acquisition Corp. located?
The principal executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301.
What is the SIC code for Drugs Made In America Acquisition Corp. and what does it represent?
The SIC code is 6770, which corresponds to 'BLANK CHECKS', indicating a shell company or a company formed for the purpose of acquisition.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding Drugs Made In America Acquisition Corp. (DMAAR).